Showing results (51-60 of 206) with videos related to
Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulinO H Clark, P L Gerend, R A NissensonExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
The regulation of proliferation and invasion in differentiated thyroid cancer by growth factorsT Hoelting, Q Y Duh, O H Clark, et al.Archives of Surgery (Chicago, Ill. : 1960)|August 2, 2000
Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancerE Kebebew, S Kikuchi, Q Y Duh, et al.Langenbecks Archiv Fur Chirurgie|January 1, 1995
[Growth and invasion of differentiated thyroid gland carcinoma: importance of signal transduction]T Hölting, O Y Duh, O H Clark, et al.Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion]T Hoelting, Q Y Duh, O H Clark, et al.Archives of Surgery (Chicago, Ill. : 1960)|August 17, 2001
Localization and reoperation results for persistent and recurrent parathyroid carcinomaE Kebebew, C Arici, Q Y Duh, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1996
Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivoT Hoelting, Q Y Duh, O H Clark, et al.Cancer Letters|April 1, 2008
Invasion of metastatic human follicular thyroid cancer is inhibited via antagonism of protein kinase CT Hoelting, Q Y Duh, O H Clark, et al.Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1994
[Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors]T Hölting, O Y Duh, O H Clark, et al.Cancer Letters|February 27, 1996
Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase CT Hoelting, Q Y Duh, O H Clark, et al.Pageof 21